Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Based on the picture, your physician designs a personalised protocol, typically a 6-12 week cycle with built-in re-assessment points
Here, we investigate a diverse panel of 12 immunomodulatory drugs as host-directed treatments (HDTs) for TB meningitis utilizing a cross-species framework comprising studies in a mouse model of TB meningitis with clinical endpoints, and parallel mechanistic studies in a newly developed immune-vascularized human brain organoid model of TB meningitis and peripheral blood mononuclear cells (PBMCs) from patients with TB meningitis
Am J Surg Pathol 2017
254 Delaruelle, Z
10.1186/1477-7827-12-13 220 WangC.SunH.DavisJ
US$ 27.64
US$ 24.20
US$ 27.71
US$ 28.17
US$ 28.01
US$ 25.15
US$ 20.88
US$ 24.58
US$ 25.12
